Beijing Med-Pharm Announces Participation in February Investor Conferences
Beijing Med-Pharm Corporation (NASDAQ: BJGP) ("Beijing Med-Pharm" or the "Company"), today announced that the Company will attend the UBS Global Healthcare Services Conference on February 11-13, 2008 in New York city, as well as the Roth Capital Partners Growth Stock Conference on February 18-21, 2008 in Dana Point, California.
Beijing Med-Pharm management is scheduled to present at the 2008 UBS Global Healthcare Services Conference at 1:00 pm ET at the Grand Hyatt in New York, New York on February 11, 2008. Management will also present at the Roth Capital Partners Growth Stock Conference at 12:30 pm PT at the Ritz Carlton Laguna Niguel in Dana Point, California on February 20, 2008. Listeners may access a live webcast of the presentations by visiting the Investor Relations portion of the Company website at www.beijingmedpharm.com.
Investors interested in attending these events should contact their UBS and Roth Capital institutional sales representatives, respectively.
About Beijing Med-Pharm Corporation
Beijing Med-Pharm Corporation, through its subsidiaries, is a pharmaceutical marketing and distribution company that is building a proprietary portfolio of branded pharmaceutical and healthcare products in China and is pursuing partnerships with other companies seeking to enter the Chinese pharmaceutical market. It is the only U.S. public company to offer industry partners a comprehensive suite of market-entry services in China that includes pre-market entry analysis, clinical trial management, product registration, market research, as well as pharmaceutical marketing and distribution. The company provides distribution services for a wide range of products, including Western medicines, traditional Chinese medicines, bio-chemical medicines, medical applications, branded generic pharmaceuticals, over-the-counter healthcare products, and home healthcare supplies and equipments. Beijing Med-Pharm's proprietary portfolio, primarily focusing on women's health and pediatrics. The Company is headquartered in Plymouth Meeting, Pennsylvania. Visit www.beijingmedpharm.com.
Source : www.newsobserver.com
Beijing Med-Pharm management is scheduled to present at the 2008 UBS Global Healthcare Services Conference at 1:00 pm ET at the Grand Hyatt in New York, New York on February 11, 2008. Management will also present at the Roth Capital Partners Growth Stock Conference at 12:30 pm PT at the Ritz Carlton Laguna Niguel in Dana Point, California on February 20, 2008. Listeners may access a live webcast of the presentations by visiting the Investor Relations portion of the Company website at www.beijingmedpharm.com.
Investors interested in attending these events should contact their UBS and Roth Capital institutional sales representatives, respectively.
About Beijing Med-Pharm Corporation
Beijing Med-Pharm Corporation, through its subsidiaries, is a pharmaceutical marketing and distribution company that is building a proprietary portfolio of branded pharmaceutical and healthcare products in China and is pursuing partnerships with other companies seeking to enter the Chinese pharmaceutical market. It is the only U.S. public company to offer industry partners a comprehensive suite of market-entry services in China that includes pre-market entry analysis, clinical trial management, product registration, market research, as well as pharmaceutical marketing and distribution. The company provides distribution services for a wide range of products, including Western medicines, traditional Chinese medicines, bio-chemical medicines, medical applications, branded generic pharmaceuticals, over-the-counter healthcare products, and home healthcare supplies and equipments. Beijing Med-Pharm's proprietary portfolio, primarily focusing on women's health and pediatrics. The Company is headquartered in Plymouth Meeting, Pennsylvania. Visit www.beijingmedpharm.com.
Source : www.newsobserver.com
Posts
Post a Comment